← Comparing 2 hypotheses side-by-side
Add hypothesis:
— Select a hypothesis to add —
TBK1 Loss Triggers Astrocyte-to-Neuron Senescence Propagatio (TBK1 → NF-κB / IRF3 / p62-autophagy / SASP effectors) — 0.00 TBK1 Loss Triggers eIF2α-Mediated Translational Repression T (TBK1, EIF2S1) — 0.00 eIF2α Phosphorylation Imbalance Disrupts Mitochondrial Prote (EIF2S1,eIF2α,PERK,GCN2,ATF4,TOMM20,TIMM23,NDUFS1,NDUFS3,COX4I1,COX5A,mitochondrial protein import) — 0.00 GluN2B-Mediated Thalamocortical Control of Glymphatic Tau Cl (GRIN2B) — 0.96 Closed-loop transcranial focused ultrasound targeting EC-II (SST) — 0.96 Closed-loop optogenetic targeting PV interneurons to restore (PVALB) — 0.95 Plasma NfL Elevation Secondary to BBB-Associated Transport D (NEFL) — 0.94 Closed-loop transcranial focused ultrasound to restore hippo (CCK) — 0.91 Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming (NLRP3, CASP1, IL1B, PYCARD) — 0.91 Gamma entrainment therapy to restore hippocampal-cortical sy (SST) — 0.90 Hypothesis 4: Metabolic Coupling via Lactate-Shuttling Colla (SLC16A1, SLC16A7, LDHA, PDHA1) — 0.89 SIRT1-Mediated Reversal of TREM2-Dependent Microglial Senesc (SIRT1) — 0.89 TREM2-Mediated Astrocyte-Microglia Crosstalk in Neurodegener (TREM2) — 0.89 Multi-Target Hypothesis: Aβ-Induced Cholinergic Damage is Pa (APP/PSEN1 (Aβ production), CHAT (cholinergic synthesis)) — 0.89 Optimized Temporal Window for Metabolic Boosting Therapy Det (IFNG) — 0.89 TREM2-APOE Axis Dissociation for Selective DAM Activation (TREM2-APOE axis) — 0.89 p38α Inhibitor and PRMT1 Activator Combination to Restore Ph (MAPK14/PRMT1) — 0.88 APOE-Dependent Autophagy Restoration (MTOR) — 0.88 Hippocampal CA3-CA1 synaptic rescue via DHHC2-mediated PSD95 (BDNF) — 0.87 ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro (ACSL4) — 0.87 Complement Cascade Inhibition Synaptic Protection (%s) — 0.87 eIF2α Phosphorylation Imbalance Creates Integrated Stress Re (EIF2S1,eIF2α,PERK,GCN2,ATF4,ATF5,CHOP,DDIT3,integrated stress response,protein synthesis) — 0.87 Optogenetic restoration of hippocampal gamma oscillations vi (PVALB) — 0.87 Glymphatic-Mediated Tau Clearance Dysfunction (MAPT) — 0.86 Closed-loop focused ultrasound targeting EC-II PV interneuro (PVALB) — 0.86 TREM2 R47H Variant-Driven Metabolic Dysfunction as the Prima (NAMPT) — 0.86 TREM2-Mediated Microglial Dysfunction Disrupts Perivascular (TREM2) — 0.86 Circadian Glymphatic Entrainment via Targeted Orexin Recepto (HCRTR1/HCRTR2) — 0.86 RBM45 Liquid-Liquid Phase Separation Dominance Hijacks RNA P (RBM45,GSK3B,TDP-43,TARDBP,hnRNP A1,HNRNPA1,phase separation,Liquid droplet) — 0.86 H6: Aberrant eIF2α Phosphorylation Creates Stalled Translati (EIF2S1, EIF2AK3/PERK, PPP1R15B, EIF2B) — 0.86
Add
|
× Gamma Oscillation Entrain × METTL3-Mediated m6A Modif
PVALB, CREB1, lncRNA-9969, neuronal autophagy pathway · molecular neurobiology · -
Composite 0.865
Price $0.76
Evidence For 0
Evidence Against 0
## Mechanistic Overview
Gamma Oscillation Entrainment Enhances lncRNA-9969-Mediated Autophagy Through PV Interneuron-Specific ceRNA Networks starts from the claim that modulating PVALB, CREB1, lncRNA-9969, neuronal autophagy pathway within the disease context of molecular neurobiology can redirect a disease-relevant process. The original description reads: "**Molecular Mechanism and Rationale** The proposed therapeutic mechanism centers on a novel circuit-RNA regulatory network that integrates g
METTL3, YTHDF2, lncRNA-0021 (m6A-modified) · molecular neurobiology · -
Composite 0.759
Price $0.70
Evidence For 0
Evidence Against 0
## **Molecular Mechanism and Rationale**
The methyltransferase-like 3 (METTL3) enzyme functions as the catalytic subunit of the m6A methyltransferase complex, working in conjunction with METTL14 and WTAP to deposit N6-methyladenosine modifications on adenosine residues within specific RNA sequences. In the context of lncRNA-0021, METTL3 catalyzes the methylation of adenosine residues at positions 180-220, creating a critical m6A modification landscape that governs the long non-coding RNA's tert
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
Neuroinflammation Protein Aggregation molecular neurobiology
Convergent signals
No same-target convergence detected in this selection.
Divergent signals
No direct polarity conflicts detected among the selected hypotheses.
Verdict Summary 9/11
dimensions won
Gamma Oscillation Entrainment Enhances l
2/11
dimensions won
METTL3-Mediated m6A Modification of lncR
Radar Chart — 10 Dimensions
Score Breakdown
Dimension Gamma Oscillation Entrainment METTL3-Mediated m6A Modificati Mechanistic 0.600 0.450 Evidence 0.500 0.350 Novelty 0.700 0.650 Feasibility 0.550 0.350 Impact 0.650 0.500 Druggability 0.400 0.550 Safety 0.400 0.350 Competition 0.500 0.650 Data 0.450 0.300 Reproducible 0.500 0.350 KG Connect 0.716 0.662
Evidence Gamma Oscillation Entrainment Enhances lncRNA-9969-Mediated No evidence citations yet
METTL3-Mediated m6A Modification of lncRNA-0021 Regulates mi No evidence citations yet
Price History Overlay